Neurobehavioral and Cardiovascular Effects of Potassium Cyanide Administered Orally to Mice.

Autor: Hawk MA; Battelle, Columbus, OH, USA., Ritchie GD; Battelle, Columbus, OH, USA., Henderson KA; Battelle, Columbus, OH, USA., Knostman KA; Battelle, Columbus, OH, USA., Roche BM; Battelle, Columbus, OH, USA., Ma ZJ; Battelle, Columbus, OH, USA., Matthews CM; Battelle, Columbus, OH, USA., Sabourin CL; Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response (ASPR), The Biomedical Advanced Research and Development Authority (BARDA), Washington, DC, USA sabourinc@battelle.org., Wakayama EJ; Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response (ASPR), The Biomedical Advanced Research and Development Authority (BARDA), Washington, DC, USA., Sabourin PJ; Battelle, Columbus, OH, USA.

Publikováno v: International journal of toxicology [Int J Toxicol] 2016 Sep; Vol. 35 (5), pp. 604-15. Date of Electronic Publication: 2016 May 11.

Animal models that best reproduce the clinical manifestations of human intoxication with organophosphorus compounds.

Autor: Pereira EF; Division of Translational Toxicology, Department of Epidemiology and Public Health (E.F.R.P., Y.A., E.X.A.), and Program of Comparative Medicine and Departments of Pathology, Medicine, and Epidemiology and Public Health (L.J.D.), University of Maryland School of Medicine, Baltimore, Maryland; Countervail Corporation, Charlotte, North Carolina (E.J.B., G.W.B.); and Biomedical Advanced Research and Development Authority and Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC (E.J.W.)., Aracava Y; Division of Translational Toxicology, Department of Epidemiology and Public Health (E.F.R.P., Y.A., E.X.A.), and Program of Comparative Medicine and Departments of Pathology, Medicine, and Epidemiology and Public Health (L.J.D.), University of Maryland School of Medicine, Baltimore, Maryland; Countervail Corporation, Charlotte, North Carolina (E.J.B., G.W.B.); and Biomedical Advanced Research and Development Authority and Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC (E.J.W.)., DeTolla LJ Jr; Division of Translational Toxicology, Department of Epidemiology and Public Health (E.F.R.P., Y.A., E.X.A.), and Program of Comparative Medicine and Departments of Pathology, Medicine, and Epidemiology and Public Health (L.J.D.), University of Maryland School of Medicine, Baltimore, Maryland; Countervail Corporation, Charlotte, North Carolina (E.J.B., G.W.B.); and Biomedical Advanced Research and Development Authority and Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC (E.J.W.)., Beecham EJ; Division of Translational Toxicology, Department of Epidemiology and Public Health (E.F.R.P., Y.A., E.X.A.), and Program of Comparative Medicine and Departments of Pathology, Medicine, and Epidemiology and Public Health (L.J.D.), University of Maryland School of Medicine, Baltimore, Maryland; Countervail Corporation, Charlotte, North Carolina (E.J.B., G.W.B.); and Biomedical Advanced Research and Development Authority and Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC (E.J.W.)., Basinger GW Jr; Division of Translational Toxicology, Department of Epidemiology and Public Health (E.F.R.P., Y.A., E.X.A.), and Program of Comparative Medicine and Departments of Pathology, Medicine, and Epidemiology and Public Health (L.J.D.), University of Maryland School of Medicine, Baltimore, Maryland; Countervail Corporation, Charlotte, North Carolina (E.J.B., G.W.B.); and Biomedical Advanced Research and Development Authority and Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC (E.J.W.)., Wakayama EJ; Division of Translational Toxicology, Department of Epidemiology and Public Health (E.F.R.P., Y.A., E.X.A.), and Program of Comparative Medicine and Departments of Pathology, Medicine, and Epidemiology and Public Health (L.J.D.), University of Maryland School of Medicine, Baltimore, Maryland; Countervail Corporation, Charlotte, North Carolina (E.J.B., G.W.B.); and Biomedical Advanced Research and Development Authority and Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC (E.J.W.)., Albuquerque EX; Division of Translational Toxicology, Department of Epidemiology and Public Health (E.F.R.P., Y.A., E.X.A.), and Program of Comparative Medicine and Departments of Pathology, Medicine, and Epidemiology and Public Health (L.J.D.), University of Maryland School of Medicine, Baltimore, Maryland; Countervail Corporation, Charlotte, North Carolina (E.J.B., G.W.B.); and Biomedical Advanced Research and Development Authority and Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC (E.J.W.) ealbuquerque@som.umaryland.edu.

Publikováno v: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2014 Aug; Vol. 350 (2), pp. 313-21. Date of Electronic Publication: 2014 Jun 06.

Cholesterol content of muscle and adipose tissue from crossbred bulls and steers.

Autor: Eichhorn JM; Medical Technology Department, University of Nevada-Reno 89557-0004, USA., Wakayama EJ, Blomquist GJ, Bailey CM

Publikováno v: Meat science [Meat Sci] 1986; Vol. 16 (1), pp. 71-8.